Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

First, a Sony and Panasonic-rivalling Pyxis 6K modular camera for indie filmmakers; the latest version of its popular video editing platform Davinci Resolve 19 – which we rate as the best free ...

BOSTON, March 27, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers ...

Blackmagic PYXIS 6K is an advanced digital film camera in a versatile box design with full frame 6K sensor in EF, PL or L-Mount model, Blackmagic RAW, and global media sync with Blackmagic Cloud - all ...

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), retaining the price target of $7.00. Swayampakula Ramakanth has given his ...

Non-dilutive funding to support development of first-in-concept lead Antibody-Drug Conjugate (ADC) asset, PYX-201 Pyxis Oncology retains rights to three other antibodies in development by Apexigen ...

Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker sector worldwide. The company operates through Tanker Vessels and Dry-Bulk Vessels segments. Its fleet ...

Non-dilutive funding to support development of first-in-concept lead Antibody-Drug Conjugate (ADC) asset, PYX-201 Pyxis Oncology retains rights to three other antibodies in development by Apexigen ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...